With experience as a venture capitalist and a CEO of two healthcare technology companies, John brings a wide-ranging perspective to Canaan. John initially joined Canaan in 2000 as a healthcare investor and served interim roles in Canaan portfolio companies over several years before being named CEO of Abyrx (formerly Orthocon) in 2010. John received a B.S. degree from Fairfield University, a MBA from Columbia Business School and is a Kauffman Fellow.
Location
New York, New York
Notable investments
No items found.
Check size range(s)
$1M - $3M
$3M - $10M
Rounds their fund invests in
Seed
Series A
Rounds their fund leads
Seed
Series A
Sectors their fund invests in
Biotech
Cybersecurity
Health
Enterprise
AI
Consumer
Fintech
Deeptech
Geographies their fund invests in
USA
Africa
LatAm
India
Asia-Pacific
Europe
Canada
Israel
ANZ
MENA
Browse through a massive startup database
Browse Harmonic, our favorite resource for parsing through the world's startup data.
Partner
Learn more about Harmonic
No items found.
No colleagues here yet.
Funds they're a part of
Canaan Partners
About the Fund
Founded in 1987, Canaan is a long-time early-stage investor currently investing out of their 12th Fund ($800M).
View Profile
Their Colleagues
Sheets Their fund(s) are in
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Related Investors
Round-focused Sheets
Geography-focused Sheets
Sector-focused Sheets
